Resistance to anti-angiogenic agents: a brief review of mechanisms and consequences

Por Edelman, Martin J., Mao, Li
Publicado no Transl Lung Cancer Res (2013)

50 Years of Progress in the Systemic Therapy of Non-Small Cell Lung Cancer

Por Wakelee, Heather, Kelly, Karen, Edelman, Martin J.
Publicado no Am Soc Clin Oncol Educ Book (2014)

The Utility of Follow-up Testing After Curative Cancer Therapy: A Critical Review and Economic Analysis

Por Edelman, Martin J, Meyers, Frederick J, Siegel, David
Publicado em 1997

Exploring the statistical and clinical impact of two interim analyses on the phase II design with option for direct assignment

Por An, Ming-Wen, Mandrekar, Sumithra J., Edelman, Martin J., Sargent, Daniel J.
Publicado em 2014

Cyclooxygenase-2 (COX-2) As a Predictive Marker for the Use of COX-2 Inhibitors in Advanced Non–Small-Cell Lung Cancer

Por Edelman, Martin J., Hodgson, Lydia, Wang, Xiaofei, Kratzke, Robert A., Vokes, Everett E.
Publicado em 2012

A Novel, Broad Spectrum Anti-Cancer Compound Containing the Imidazo[4,5-e][1,3]diazepine Ring System

Por Xie, Min, Ujjinamatada, Ravi K., Sadowska, Mariola, Lapidus, Rena G., Edelman, Martin J., Hosmane, Ramachandra S.
Publicado em 2010

MHC II Lung Cancer Vaccines Prime and Boost Tumor-specific CD4(+) T Cells that Cross-React with Multiple Histologic Subtypes of Non-small Cell Lung Cancer Cells

Por Srivastava, Minu K., Bosch, Jacobus J., Wilson, Ashley L., Edelman, Martin J., Ostrand-Rosenberg, Suzanne
Publicado em 2010

Serum Vascular Endothelial Growth Factor and COX-2/5-LOX Inhibition in Advanced Non-small Cell Lung Cancer: Cancer and Leukemia Group B 150304

Por Edelman, Martin J., Hodgson, Lydia, Wang, Xiaofei, Christenson, Robert, Jewell, Scott, Vokes, Everett, Kratzke, Robert
Publicado no J Thorac Oncol (2011)

Daily Diary Study of Hope, Stigma, and Functioning in Lung Cancer Patients

Por Steffen, Laurie E., Vowles, Kevin E., Smith, Bruce W., Gan, Gregory N., Edelman, Martin J.
Publicado no Health Psychol (2017)

Anti-HDGF targets cancer and cancer stromal stem cells resistant to chemotherapy

Por Zhao, Jun, Ma, Mark Z., Ren, Hening, Liu, Zhenqiu, Edelman, Martin J., Pan, Hong, Mao, Li
Publicado em 2013

Validation of Disability Status, a Claims-Based Measure of Functional Status for Cancer Treatment and Outcomes Studies

Por Davidoff, Amy J., Gardner, Lisa D., Zuckerman, Ilene H., Hendrick, Franklin, Ke, Xuehua, Edelman, Martin J.
Publicado no Med Care (2014)

CYFRA 21-1 as a prognostic and predictive marker in advanced non-small cell lung cancer in a prospective trial: CALGB 150304

Por Edelman, Martin J., Hodgson, Lydia, Rosenblatt, Paula Y., Christenson, Robert H., Vokes, Everett, Wang, Xiaofei, Kratzke, Robert
Publicado no J Thorac Oncol (2012)

Lung cancer patients’ CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells

Por Srivastava, Minu K., Bosch, Jacobus J., Thompson, James A., Ksander, Bruce R., Edelman, Martin J., Ostrand-Rosenberg, Suzanne
Publicado em 2008

CDC25A(Q110del): A Novel Cell Division Cycle 25A Isoform Aberrantly Expressed in Non-Small Cell Lung Cancer

Por Younis, Rania H., Cao, Wei, Lin, Ruxian, Xia, Ronghui, Liu, Zhenqiu, Edelman, Martin J., Mei, Yuping, Mao, Li, Ren, Hening
Publicado em 2012

Structure-based drug design and potent anti-cancer activity of tricyclic 5:7:5-fused diimidazo[4,5-d:4′,5′-f][1,3]diazepines

Por Kondaskar, Atul, Kondaskar, Shilpi, Fishbein, James C., Carter-Cooper, Brandon A., Lapidus, Rena G., Sadowska, Mariola, Edelman, Martin J., Hosmane, Ramachandra S.
Publicado em 2012

GP88 (Progranulin): A novel tissue and circulating biomarker for non-small cell lung carcinoma

Por Edelman, Martin J., Feliciano, Josephine, Yue, Binbin, Bejarano, Pablo, Ioffe, Olga, Reisman, David, Hawkins, Douglas, Gai, Qiwei, Hicks, David, Serrero, Ginette
Publicado em 2014

The Benefit of Chemotherapy in Esophageal Cancer Patients With Residual Disease After Trimodality Therapy

Por Kim, Grace J., Koshy, Matthew, Hanlon, Alexandra L., Horiba, M. Naomi, Edelman, Martin J., Burrows, Whitney M., Battafarano, Richard J., Suntharalingam, Mohan
Publicado no Am J Clin Oncol (2016)

Epidermal Growth Factor Receptor (EGFR) Mutations in Small Cell Lung Cancers: Two Cases and a Review of the Literature

Por Siegele, Bradford J., Shilo, Konstantin, Chao, Bo H., Carbone, David, Zhao, Weiqiang, Ioffe, Olga, Franklin, Wilbur A., Edelman, Martin J., Aisner, Dara L.
Publicado no Lung Cancer (2016)

Stereotactic Ablative Radiotherapy (SABR): Impact on the Immune System and Potential for Future Therapeutic Modulation

Por Reese, Adam S., Feigenberg, Steven J., Husain, Azmat, Webb, Tonya J, Hausner, Petr F., Edelman, Martin J., Feliciano, Josephine, Tkaczuk, Katherine H., Sharma, Navesh K.
Publicado em 2013

A Novel Approach to Improve Health Status Measurement in Observational Claims-based Studies of Cancer Treatment and Outcomes

Por Davidoff, Amy J., Hurria, Arti, Zuckerman, Ilene H., Lichtman, Stuart M., Pandya, Naimish, Hussain, Arif, Hendrick, Franklin, Weiner, Jonathan P, Ke, Xuehua, Edelman, Martin J.
Publicado em 2013